An Australian man’s attempt to save his sick dog has turned into a surprising real-world example of how AI is starting to influence medical research.
Paul Conyngham, a Sydney-based AI consultant, used tools like ChatGPT, Gemini, and Grok to research treatment options for his dog Rosie, who was diagnosed with mast cell cancer.
Instead of stopping at basic advice, he went much deeper. Over several months, he used AI to study cancer science, explore experimental therapies, and even identify researchers who could help.
His efforts eventually led him to pay for Rosie’s genome sequencing. He then used AI tools again to help interpret the genetic data and better understand the disease at a molecular level.
With guidance from AI and academic contacts, Conyngham connected with researchers at the University of New South Wales, who helped turn the idea into a real experimental treatment approach involving an mRNA-based vaccine and immunotherapy.
He also used AI suggestions to find experts at the University of Queensland who could assist with administering parts of the treatment.
After receiving the therapy in December, Rosie’s condition reportedly improved. The largest tumour shrank significantly, and she regained some mobility and energy. However, her overall condition is still uncertain, and it is not being described as a cure.
Experts involved in the case, including researchers from UNSW, stressed that this was not a formal clinical trial and that it’s unclear exactly how much the treatment or AI contributed to the outcome.
Still, they say the combination of technologies—AI analysis, genome sequencing, and mRNA therapeutics—shows strong potential for the future of medicine.
The story even caught the attention of Sam Altman, who called it an “amazing story” on social media.
Scientists interviewed noted that AI can help speed up medical research by quickly analyzing huge amounts of data and suggesting possible treatments that humans might overlook. But they also warned that mistakes and misinformation remain a real risk if such tools are used without proper expertise.
Researchers like AlphaFold were also mentioned in the process, showing how advanced AI systems are increasingly being used in biology and drug research.
In the end, Rosie’s case is not proof of an AI cure—but it is a powerful example of how modern AI tools are starting to connect everyday people with cutting-edge science in ways that weren’t possible before.
It also highlights a growing trend: AI is no longer just for answering questions—it’s starting to actively shape how people approach real-world problems, even in medicine.
